Cargando…
Myocardial infarction complicating critical illness
Cardiac troponins are highly sensitive and specific indicators of myocardial injury. Although the mechanism of this injury is not entirely clear, it carries important prognostic information. Elevated serum levels of cardiac troponins have been described in a wide variety of conditions other than myo...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1414037/ https://www.ncbi.nlm.nih.gov/pubmed/16356252 http://dx.doi.org/10.1186/cc3893 |
_version_ | 1782127111347109888 |
---|---|
author | King, Daniel A Almog, Yaniv |
author_facet | King, Daniel A Almog, Yaniv |
author_sort | King, Daniel A |
collection | PubMed |
description | Cardiac troponins are highly sensitive and specific indicators of myocardial injury. Although the mechanism of this injury is not entirely clear, it carries important prognostic information. Elevated serum levels of cardiac troponins have been described in a wide variety of conditions other than myocardial infarction (MI). The current study is an important first step in trying to determine the exact frequency of MI among critically ill patients with elevated troponin. At present, the rate of MI in these patients is unknown and its implications on outcome and management will have to await future prospective clinical trials. |
format | Text |
id | pubmed-1414037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-14140372006-03-28 Myocardial infarction complicating critical illness King, Daniel A Almog, Yaniv Crit Care Commentary Cardiac troponins are highly sensitive and specific indicators of myocardial injury. Although the mechanism of this injury is not entirely clear, it carries important prognostic information. Elevated serum levels of cardiac troponins have been described in a wide variety of conditions other than myocardial infarction (MI). The current study is an important first step in trying to determine the exact frequency of MI among critically ill patients with elevated troponin. At present, the rate of MI in these patients is unknown and its implications on outcome and management will have to await future prospective clinical trials. BioMed Central 2005 2005-11-02 /pmc/articles/PMC1414037/ /pubmed/16356252 http://dx.doi.org/10.1186/cc3893 Text en Copyright © 2005 BioMed Central Ltd |
spellingShingle | Commentary King, Daniel A Almog, Yaniv Myocardial infarction complicating critical illness |
title | Myocardial infarction complicating critical illness |
title_full | Myocardial infarction complicating critical illness |
title_fullStr | Myocardial infarction complicating critical illness |
title_full_unstemmed | Myocardial infarction complicating critical illness |
title_short | Myocardial infarction complicating critical illness |
title_sort | myocardial infarction complicating critical illness |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1414037/ https://www.ncbi.nlm.nih.gov/pubmed/16356252 http://dx.doi.org/10.1186/cc3893 |
work_keys_str_mv | AT kingdaniela myocardialinfarctioncomplicatingcriticalillness AT almogyaniv myocardialinfarctioncomplicatingcriticalillness |